TD Asset Management
VRTX icon

TD Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$207M Sell
465,173
-20,683
-4% -$9.21M 0.18% 121
2025
Q1
$236M Buy
485,856
+16,788
+4% +$8.14M 0.22% 93
2024
Q4
$189M Sell
469,068
-53,137
-10% -$21.4M 0.17% 128
2024
Q3
$242M Buy
522,205
+18,151
+4% +$8.4M 0.21% 104
2024
Q2
$236M Sell
504,054
-11,346
-2% -$5.32M 0.22% 102
2024
Q1
$215M Sell
515,400
-18,513
-3% -$7.74M 0.2% 113
2023
Q4
$217M Buy
533,913
+53,850
+11% +$21.9M 0.21% 91
2023
Q3
$167M Buy
480,063
+103,097
+27% +$35.9M 0.2% 90
2023
Q2
$133M Sell
376,966
-9,620
-2% -$3.39M 0.15% 120
2023
Q1
$122M Buy
386,586
+6,572
+2% +$2.07M 0.15% 128
2022
Q4
$110M Sell
380,014
-59,581
-14% -$17.2M 0.14% 133
2022
Q3
$129M Sell
439,595
-1,946
-0.4% -$570K 0.16% 112
2022
Q2
$124M Buy
441,541
+4,975
+1% +$1.4M 0.14% 126
2022
Q1
$114M Buy
436,566
+106,787
+32% +$27.9M 0.1% 155
2021
Q4
$72.4M Buy
329,779
+9,855
+3% +$2.16M 0.06% 244
2021
Q3
$58M Sell
319,924
-25,689
-7% -$4.66M 0.06% 247
2021
Q2
$69.7M Sell
345,613
-134,074
-28% -$27M 0.07% 226
2021
Q1
$103M Sell
479,687
-122,706
-20% -$26.4M 0.12% 141
2020
Q4
$142M Sell
602,393
-18,348
-3% -$4.34M 0.17% 110
2020
Q3
$169M Buy
620,741
+28,773
+5% +$7.83M 0.23% 90
2020
Q2
$172M Buy
591,968
+11,139
+2% +$3.23M 0.24% 86
2020
Q1
$138M Buy
580,829
+22,345
+4% +$5.32M 0.23% 88
2019
Q4
$122M Sell
558,484
-10,495
-2% -$2.3M 0.18% 114
2019
Q3
$96.4M Buy
568,979
+31,902
+6% +$5.4M 0.15% 134
2019
Q2
$98.5M Buy
537,077
+17,903
+3% +$3.28M 0.15% 124
2019
Q1
$95.5M Buy
519,174
+16,768
+3% +$3.08M 0.15% 122
2018
Q4
$83.3M Buy
502,406
+10,202
+2% +$1.69M 0.14% 127
2018
Q3
$94.9M Buy
492,204
+34,971
+8% +$6.74M 0.14% 134
2018
Q2
$77.7M Sell
457,233
-44,008
-9% -$7.48M 0.12% 152
2018
Q1
$81.7M Buy
501,241
+12,868
+3% +$2.1M 0.13% 150
2017
Q4
$73.2M Buy
488,373
+36,133
+8% +$5.41M 0.11% 160
2017
Q3
$68.8M Buy
452,240
+18,513
+4% +$2.81M 0.1% 158
2017
Q2
$55.9M Buy
433,727
+22,057
+5% +$2.84M 0.09% 181
2017
Q1
$45M Buy
411,670
+18,884
+5% +$2.06M 0.07% 215
2016
Q4
$28.9M Sell
392,786
-52,358
-12% -$3.86M 0.05% 287
2016
Q3
$38.8M Sell
445,144
-247
-0.1% -$21.5K 0.07% 232
2016
Q2
$38.3M Sell
445,391
-19,698
-4% -$1.69M 0.07% 225
2016
Q1
$37M Buy
465,089
+39,905
+9% +$3.17M 0.07% 223
2015
Q4
$53.5M Buy
425,184
+47,550
+13% +$5.98M 0.11% 167
2015
Q3
$39.3M Buy
377,634
+58,300
+18% +$6.07M 0.08% 206
2015
Q2
$39.4M Buy
319,334
+724
+0.2% +$89.4K 0.07% 208
2015
Q1
$37.6M Buy
318,610
+16,282
+5% +$1.92M 0.07% 223
2014
Q4
$35.9M Buy
302,328
+7,475
+3% +$888K 0.06% 225
2014
Q3
$33.1M Buy
294,853
+6,227
+2% +$699K 0.06% 240
2014
Q2
$27.3M Buy
288,626
+31,200
+12% +$2.95M 0.05% 268
2014
Q1
$18.2M Buy
257,426
+11,800
+5% +$834K 0.03% 341
2013
Q4
$18.3M Buy
245,626
+36,100
+17% +$2.68M 0.03% 324
2013
Q3
$15.9M Buy
209,526
+112,800
+117% +$8.55M 0.03% 336
2013
Q2
$7.73M Buy
+96,726
New +$7.73M 0.02% 476